Joint announcement sends Intel shares soaring in premarket trading. ...

Intel will build Nvidia-custom x86 CPUs that Nvidia will integrate into its AI infrastructure platforms. ...

The software giant announced a slew of new artificial-intelligence bots this week as it aims to win over business customers with the nascent technology. ...

Core Viewpoint - The central bank's quarter-point rate cut has effectively removed the worst-case scenarios for the U.S. economy [1] Group 1 - The rate cut is expected to stabilize economic conditions and support growth [1] - This monetary policy adjustment reflects a proactive approach to managing economic risks [1] - The decision indicates confidence in the economy's resilience despite potential challenges [1]

While the Federal Reserve has begun cutting rates again, there are many other factors that affect the cost of home loans. ...

The overtures mark a shift in the Facebook parent's relationships with news outlets and other publishers. ...

Core Viewpoint - The central bank has reduced its interest rate to 4% and indicated that further easing will likely be necessary to stimulate economic growth, with expectations of one rate cut per year over the next three years [1] Group 1 - The central bank's current interest rate is set at 4% [1] - Policymakers anticipate the need for additional rate cuts to support economic growth [1] - A forecast of one rate cut per year is expected for the next three years [1]

Core Viewpoint - The Bank of England is set to announce its interest-rate decision on Thursday, which is highly anticipated by market participants and analysts [1] Group 1 - The decision is expected to have significant implications for the UK economy and financial markets [1] - Analysts are closely monitoring inflation trends and economic indicators leading up to the announcement [1] - The outcome of the interest-rate decision could influence borrowing costs and consumer spending in the UK [1]

Production is under way and the pill, which helped patients lose an average 16.6% of their weight, is pending regulatory approval in the U.S. ...

The deal seeks to strengthen the drugmaker's pipeline by adding an experimental drug for an obesity comorbidity. ...